Role of Tivozanib in Renal Cell Carcinoma (RCC) - Episode 3
Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.
Related Content:
Pregnancy-Associated Hematological Malignancies Linked With Complications
Counting Blessings Is Key to Living With Cancer
Phase 2 Study Assessing Alisertib in Metastatic Breast Cancer Subset Begins
How I Truly Learned to Live With Stage 4 Colon Cancer